Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Antituberculous Treatment Itself Might Prevent Visual Impairment in Presumed Tuberculosis-Related Uveitis.

Llorenç V, Benejam G, Mesquida M, Sainz de la Maza M, Molins B, Alba C, Pelegrin L, Martínez JA, Adán A.

Ocul Immunol Inflamm. 2018 Nov 5:1-8. doi: 10.1080/09273948.2018.1541326. [Epub ahead of print]

PMID:
30395738
2.

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.

Martín-Varillas JL, Calvo-Río V, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Garfella MH, Pascual EV, Martínez-Costa L, Sellas-Fernández A, Cordero-Coma M, Díaz-Llopis M, Gallego R, Salom D, Ortego N, García-Serrano JL, Callejas-Rubio JL, Herreras JM, García-Aparicio Á, Maíz O, Blanco A, Torre I, Díaz-Valle D, Pato E, Aurrecoechea E, Caracuel MA, Gamero F, Minguez E, Carrasco-Cubero C, Olive A, Vázquez J, Ruiz-Moreno O, Manero J, Muñoz-Fernández S, Martinez MG, Rubio-Romero E, Toyos-Sáenz de Miera FJ, López Longo FJ, Nolla JM, Revenga M, González-Vela C, Loricera J, Atienza-Mateo B, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.

Ophthalmology. 2018 Sep;125(9):1444-1451. doi: 10.1016/j.ophtha.2018.02.020. Epub 2018 Mar 27.

PMID:
29602570
3.

Reply.

Mesquida M, Llorenc V, Adan A.

Med Clin (Barc). 2018 Oct 23;151(8):336-337. doi: 10.1016/j.medcli.2018.02.005. Epub 2018 Mar 7. English, Spanish. No abstract available.

PMID:
29525112
4.

Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review.

Palmou-Fontana N, Calvo-Río V, Martín-Varillas JL, Fernández-Díaz C, Mesquida M, Adán A, Hernández MV, Cordero-Coma M, Maiz Alonso O, Díaz-Valle D, Fernández-Cid C, Ruiz-Moreno O, Hernández JL, González-Gay MA, Blanco R.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):652-657. Epub 2017 Dec 15. Review.

5.

Targeting interleukin-6 in autoimmune uveitis.

Mesquida M, Molins B, Llorenç V, de la Maza MS, Adán A.

Autoimmun Rev. 2017 Oct;16(10):1079-1089. doi: 10.1016/j.autrev.2017.08.002. Epub 2017 Aug 2. Review.

PMID:
28778705
6.

New imaging techniques in retinal vasculitis.

Mesquida M, Llorens V, Adán A.

Med Clin (Barc). 2017 Sep 20;149(6):261-266. doi: 10.1016/j.medcli.2017.05.009. Epub 2017 Jul 5. Review. English, Spanish.

PMID:
28687121
7.

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.

Mesquida M, Molins B, Llorenç V, Hernández MV, Espinosa G, Sainz de la Maza M, Adán A.

Retina. 2018 Jul;38(7):1361-1370. doi: 10.1097/IAE.0000000000001690.

PMID:
28520640
8.

Bacillus Calmette-Guérin Infection and Cytotoxicity in the Retinal Pigment Epithelium.

Llorenç V, Mesquida M, Molins B, González-Martín J, Sainz de la Maza M, Adán A.

Ocul Immunol Inflamm. 2018;26(5):786-792. doi: 10.1080/09273948.2016.1265655. Epub 2016 Dec 23.

PMID:
28010156
9.

C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function.

Molins B, Pascual A, Méndez, Llorenç V, Zarranz-Ventura J, Mesquida M, Adán A, Martorell J.

Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C244-C253. doi: 10.1152/ajpcell.00057.2016. Epub 2016 Dec 21.

10.

The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.

Santos-Gómez M, Calvo-Río V, Blanco R, Beltrán E, Mesquida M, Adán A, Cordero-Coma M, García-Aparicio ÁM, Valls Pascual E, Martínez-Costa L, Hernández MV, Hernandez Garfella M, González-Vela MC, Pina T, Palmou-Fontana N, Loricera J, Hernández JL, González-Gay MA.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S34-S40. Epub 2016 Apr 7.

PMID:
27054359
11.

Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.

Calvo-Río V, Santos-Gómez M, Calvo I, González-Fernández MI, López-Montesinos B, Mesquida M, Adán A, Hernández MV, Maíz O, Atanes A, Bravo B, Modesto C, Díaz-Cordovés G, Palmou-Fontana N, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.

Arthritis Rheumatol. 2017 Mar;69(3):668-675. doi: 10.1002/art.39940.

12.

Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.

Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.

J Rheumatol. 2016 Dec;43(12):2183-2188. Epub 2016 Sep 15.

PMID:
27633821
13.

In Response to: "Deuter CM, Zierhut M, Igney-Oertel A, et al. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment".

Mesquida M, Llorenç V, Adán A.

Ocul Immunol Inflamm. 2017 Apr;25(2):221-222. doi: 10.3109/09273948.2016.1145240. Epub 2016 Mar 25. No abstract available.

PMID:
27014943
14.

Interleukin-22 serum levels are elevated in active scleritis.

Sainz-de-la-Maza M, Molins B, Mesquida M, Llorenç V, Zarranz-Ventura J, Sala-Puigdollers A, Matas J, Adan A, Foster CS.

Acta Ophthalmol. 2016 Sep;94(6):e395-9. doi: 10.1111/aos.13005. Epub 2016 Mar 24.

15.

Elevated Serum Immune Mediators and Subclinical Inflammation in HLA-A29-associated Birdshot Chorioretinopathy.

Molins B, Mesquida M, Llorenç V, Sainz de la Maza M, Adán A.

Ocul Immunol Inflamm. 2016 Dec;24(6):647-652. Epub 2015 Dec 8.

PMID:
26645126
16.

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.

Riancho-Zarrabeitia L, Calvo-Río V, Blanco R, Mesquida M, Adan AM, Herreras JM, Aparicio Á, Peiteado-Lopez D, Cordero-Coma M, García Serrano JL, Ortego-Centeno N, Maíz O, Blanco A, Sánchez-Bursón J, González-Suárez S, Fonollosa A, Santos-Gómez M, González-Vela C, Loricera J, Pina T, González-Gay MA.

Semin Arthritis Rheum. 2015 Dec;45(3):361-8. doi: 10.1016/j.semarthrit.2015.05.010. Epub 2015 May 21.

PMID:
26092330
17.

Uveitic macular oedema after treatment with vemurafenib.

Fonollosa A, Mesquida M, Adan A.

Acta Ophthalmol. 2015 Dec;93(8):e686-7. doi: 10.1111/aos.12678. Epub 2015 Feb 13. No abstract available.

18.

Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization.

Llorenç V, Mesquida M, Sainz de la Maza M, Keller J, Molins B, Espinosa G, Hernandez MV, Gonzalez-Martín J, Adán A.

Acta Ophthalmol. 2015 Sep;93(6):561-7. doi: 10.1111/aos.12675. Epub 2015 Feb 15.

19.

Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.

Molins B, Mesquida M, Lee RW, Llorenç V, Pelegrín L, Adán A.

Clin Exp Immunol. 2015 Mar;179(3):529-38. doi: 10.1111/cei.12479.

20.

Certolizumab Pegol, a New Anti-TNF-α in the Armamentarium against Ocular Inflammation.

Llorenç V, Mesquida M, Sainz de la Maza M, Blanco R, Calvo V, Maíz O, Blanco A, de Dios-Jiménez de Aberásturi JR, Adán A.

Ocul Immunol Inflamm. 2016;24(2):167-72. doi: 10.3109/09273948.2014.967779. Epub 2014 Oct 17.

PMID:
25325834

Supplemental Content

Loading ...
Support Center